Trial intelligence / Profile preview

Erythropoietin for Erectile Function Recovery Post-Prostatectomy

NCT00737893Phase 2Completed

Sponsor
Johns Hopkins University
Start
Jul 2017
Primary completion
Dec 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of erythropoietin in erectile dysfunction (ED), sponsored by Johns Hopkins University. Started Jul 2017; status: completed.

02

Drugs

erythropoietin
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00737893.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00737893.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call